FDA Warning About a Bad Batch of Botox
January 14, 2013
The FDA sent a letter to more than 350 medical practices about a batch of Botox sent by Canada Drugs. They say they can’t ensure the drug’s effectiveness or safety.
Topics:
Health Medical Pharma, Disaster Accident, Social Issues, Medicine, Food and Drug Administration, Pharmaceutical sciences, FDA Warning Letter, pharmaceutical industry, Plastic surgery, Neurotoxins, Botulinum toxin, Pharmacology, Clinical research
